Clinical Trials Logo

Clinical Trial Summary

To clarify the changes of intestinal flora - gut - brain axis in FGIDs patients represented by NERD disharmony of liver and stomach and IBS-D disharmony of liver and spleen, and confirm that the imbalance between intestinal flora and host co-metabolism is the key to the pathogenesis of functional gastrointestinal disease. To reveal the common mechanism of regulating liver and spleen (stomach) in treating FGIDs dynamic disorder and visceral hypersensitivity by regulating intestinal flora - intestine - brain axis disorder.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04454996
Study type Interventional
Source Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contact lin lv
Phone 18811782728
Email lushangshitou@qq.com
Status Recruiting
Phase Phase 4
Start date June 25, 2020
Completion date March 30, 2022